LYSODREN (E.R. Squibb & Sons, L.L.C.)


Welcome to the PulseAid listing for the LYSODREN drug offered from E.R. Squibb & Sons, L.L.C.. This Cytochrome P450 3A4 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: E.R. Squibb & Sons, L.L.C.
NON-PROPRIETARY NAME: MITOTANE
SUBSTANCE NAME: MITOTANE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytochrome P450 3A4 Inducers [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-06-01
END MARKETING DATE: 0000-00-00


LYSODREN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLYSODREN from E.R. Squibb & Sons, L.L.C.
LABELER NAME: E.R. Squibb & Sons, L.L.C.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2009-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0015-3080_f7300281-bca8-4dba-ba90-258712a76093
PRODUCT NDC: 0015-3080
APPLICATION NUMBER: NDA016885

Other MITOTANE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
E.R. Squibb & Sons, L.L.C.LYSODREN